Watts Ryan J.
SEC insider (Form 3/4/5 filer). CIK 0001724310. President and CEO at Denali Therapeutics Inc. (DNLI). 12 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Watts Ryan J. has filed insider reports for
- Denali Therapeutics Inc. (DNLI): Director, Officer, President and CEO
Watts Ryan J.
CIK: 0001724310
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Denali Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Aug 12, 2026DNLI
Denali Therapeutics Inc.
GiftIndirect32.2K shares- - Jan 6, 2026DNLI
Denali Therapeutics Inc.
SaleDirect35.2K shares at avg. $16.50$581K - Jan 3, 2026DNLI
Denali Therapeutics Inc.
AwardDirect79K shares- - Sep 3, 2025DNLI
Denali Therapeutics Inc.
GiftIndirect50K shares- - Jul 9, 2025DNLI
Denali Therapeutics Inc.
SaleDirect495.3K shares at avg. $15.00$7.4M - Jul 9, 2025DNLI
Denali Therapeutics Inc.
ExerciseDirect455.3K shares at avg. $0.68$310K - Jul 9, 2025DNLI
Denali Therapeutics Inc.
ExerciseDirect40K shares at avg. $5.28$211K - Jan 7, 2025DNLI
Denali Therapeutics Inc.
SaleDirect7.7K shares at avg. $20.81$159K - Jan 6, 2025DNLI
Denali Therapeutics Inc.
SaleDirect29.3K shares at avg. $20.22$592K - Jan 3, 2025DNLI
Denali Therapeutics Inc.
AwardDirect54.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | DNLI Denali Therapeutics Inc. | Gift | 32,220 | - | $0 | Indirect |
| Jan 6, 2026 | DNLI Denali Therapeutics Inc. | Sale | 35,198 | $16.50 | $580,767 | Direct |
| Jan 3, 2026 | DNLI Denali Therapeutics Inc. | Award | 78,960 | - | $0 | Direct |
| Sep 3, 2025 | DNLI Denali Therapeutics Inc. | Gift | 50,000 | - | - | Indirect |
| Jul 9, 2025 | DNLI Denali Therapeutics Inc. | Sale | 495,282 | $15.00 | $7,429,230 | Direct |
| Jul 9, 2025 | DNLI Denali Therapeutics Inc. | Exercise | 455,282 | $0.68 | $309,592 | Direct |
| Jul 9, 2025 | DNLI Denali Therapeutics Inc. | Exercise | 40,000 | $5.28 | $211,200 | Direct |
| Jan 7, 2025 | DNLI Denali Therapeutics Inc. | Sale | 7,650 | $20.81 | $159,197 | Direct |
| Jan 6, 2025 | DNLI Denali Therapeutics Inc. | Sale | 29,266 | $20.22 | $591,759 | Direct |
| Jan 3, 2025 | DNLI Denali Therapeutics Inc. | Award | 54,180 | - | $0 | Direct |
1-10 of 12 transactions